BACE1 and Alzheimer disease: In a recent study, BC200 RNA was discovered in quantifiable levels specifically in AD patients compared to a gradual decreasing trend seen in the normal age-matched control group [69], and suppressing BC200 inhibited BACE1 expression [70].